+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Veterinary Medicine in Europe

  • PDF Icon

    Report

  • 43 Pages
  • September 2025
  • Region: Europe
  • GlobalData
  • ID: 6041330
Veterinary Medicine in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • Veterinary medicine is concerned with preventing, controlling, diagnosing, and treating diseases affecting the health of both food-producing and companion animals and preventing the transmission of animal diseases to humans.
  • The European veterinary medicine market recorded revenues of $8.85 billion in 2024, representing a compound annual growth rate (CAGR) of 5.8% between 2019 and 2024.
  • The pharmaceutical segment accounted for the market's largest proportion in 2024, with total revenues of $3.42 billion, equivalent to 38.7% of the market's overall value.
  • Europe accounted for a share of 26.5% of the global veterinary medicine market in 2024.

Report Scope

  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the veterinary medicine market in Europe
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the veterinary medicine market in Europe
  • Leading company profiles reveal details of key veterinary medicine market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Europe veterinary medicine market with five year forecasts by both value and volume

Reasons to Buy

  • What was the size of the Europe veterinary medicine market by value in 2024?
  • What will be the size of the Europe veterinary medicine market in 2029?
  • What factors are affecting the strength of competition in the Europe veterinary medicine market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Europe's veterinary medicine market?

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What are the recent developments in the market?
8 Company Profiles
8.1. Boehringer Ingelheim International GmbH
8.2. Merck & Co Inc
8.3. Zoetis Inc
8.4. Virbac SA
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related the analyst research
10.4. About the Analyst
List of Tables
Table 1: Europe veterinary medicine market value: $ million, 2019-24
Table 2: Europe veterinary medicine market category segmentation: % share, by value, 2019-24
Table 3: Europe veterinary medicine market category segmentation: $ million, 2019-24
Table 4: Europe veterinary medicine market geography segmentation: $ million, 2024
Table 5: Europe veterinary medicine market value forecast: $ million, 2024-29
Table 6: Boehringer Ingelheim International GmbH: Key Facts
Table 7: Boehringer Ingelheim International GmbH: key employees
Table 8: Merck & Co Inc: Key Facts
Table 9: Merck & Co Inc: annual financial ratios
Table 10: Merck & Co Inc: key employees
Table 11: Zoetis Inc: Key Facts
Table 12: Zoetis Inc: annual financial ratios
Table 13: Zoetis Inc: key employees
Table 14: Virbac SA: Key Facts
Table 15: Virbac SA: annual financial ratios
Table 16: Virbac SA: key employees
Table 17: Europe Size of Population (Million), 2020-24
Table 18: Europe Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 19: Europe GDP (Current Prices, $ Billion), 2020-24
Table 20: Europe Inflation, 2020-24
Table 21: Europe Consumer Price Index (Absolute), 2020-24
Table 22: Europe Exchange Rate, 2019-24
List of Figures
Figure 1: Europe veterinary medicine market value: $ million, 2019-24
Figure 2: Europe veterinary medicine market category segmentation: $ million, 2019-24
Figure 3: Europe veterinary medicine market geography segmentation: % share, by value, 2024
Figure 4: Europe veterinary medicine market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the veterinary medicine market in Europe, 2024
Figure 6: Drivers of buyer power in the veterinary medicine market in Europe, 2024
Figure 7: Drivers of supplier power in the veterinary medicine market in Europe, 2024
Figure 8: Factors influencing the likelihood of new entrants in the veterinary medicine market in Europe, 2024
Figure 9: Factors influencing the threat of substitutes in the veterinary medicine market in Europe, 2024
Figure 10: Drivers of degree of rivalry in the veterinary medicine market in Europe, 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Boehringer Ingelheim International GmbH
  • Merck & Co Inc
  • Zoetis Inc
  • Virbac SA